Related references
Note: Only part of the references are listed.Integrative analysis of 111 reference human epigenomes
Anshul Kundaje et al.
NATURE (2015)
Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers
Suna Onengut-Gumuscu et al.
NATURE GENETICS (2015)
Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
Jennifer G. Robinson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events
Marc S. Sabatine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
A New Initiative on Precision Medicine
Francis S. Collins et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritis
John Bowes et al.
NATURE COMMUNICATIONS (2015)
Comparative Genomic Profiling of Synovium Versus Skin Lesions in Psoriatic Arthritis
Jennifer Belasco et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Genetic and epigenetic fine mapping of causal autoimmune disease variants
Kyle Kai-How Farh et al.
NATURE (2015)
Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo-controlled, phase II proof-of-concept trial
Iain B. McInnes et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Ustekinumab for the treatment of patients with active ankylosing spondylitis: results of a 28-week, prospective, open-label, proof-of-concept study (TOPAS)
Denis Poddubnyy et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Not all monoclonals are created equal - Lessons from failed drug trials in Crohn's disease
Arthur Kaser
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2014)
Tissue-Resident Macrophage Enhancer Landscapes Are Shaped by the Local Microenvironment
Yonit Lavin et al.
CELL (2014)
Recent developments in the treatment of patients with systemic lupus erythematosus: focusing on biologic therapies
Zozik Fattah et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2014)
Anatomical localization of commensal bacteria in immune cell homeostasis and disease
Thomas C. Fung et al.
IMMUNOLOGICAL REVIEWS (2014)
Genetics of rheumatoid arthritis contributes to biology and drug discovery
Yukinori Okada et al.
NATURE (2014)
Guidelines for investigating causality of sequence variants in human disease
D. G. MacArthur et al.
NATURE (2014)
PTPN22: the archetypal non-HLA autoimmunity gene
Stephanie M. Stanford et al.
NATURE REVIEWS RHEUMATOLOGY (2014)
Brodalumab, an Anti-IL17RA Monoclonal Antibody, in Psoriatic Arthritis
Philip J. Mease et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
A 52-Week Placebo-Controlled Trial of Evolocumab in Hyperlipidemia
Dirk J. Blom et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Secukinumab in Plaque Psoriasis - Results of Two Phase 3 Trials
Richard G. Langley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4
Hye Sun Kuehn et al.
SCIENCE (2014)
Innate Immune Activity Conditions the Effect of Regulatory Variants upon Monocyte Gene Expression
Benjamin P. Fairfax et al.
SCIENCE (2014)
Statin-Related Cognitive Impairment in the Real World You'll Live Longer, but You Might Not Like It
Jonathan McDonagh
JAMA INTERNAL MEDICINE (2014)
The Human Skin-Associated Autoantigen α-NAC Activates Monocytes and Dendritic Cells via TLR-2 and Primes an IL-12-Dependent Th1 Response
Susanne Hradetzky et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial
Iain B. McInnes et al.
LANCET (2013)
Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial
Dominique Baeten et al.
LANCET (2013)
Toward a cytokine-based disease taxonomy
Georg Schett et al.
NATURE MEDICINE (2013)
Genetic insights into common pathways and complex relationships among immune-mediated diseases
Miles Parkes et al.
NATURE REVIEWS GENETICS (2013)
Genome-Wide Association Study and Gene Expression Analysis Identifies CD84 as a Predictor of Response to Etanercept Therapy in Rheumatoid Arthritis
Jing Cui et al.
PLOS GENETICS (2013)
Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis
Jose U. Scher et al.
ELIFE (2013)
Ustekinumab in the treatment of psoriatic arthritis: latest findings and clinical potential
Alice Gottlieb et al.
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2013)
Population genetic tools for dissecting innate immunity in humans
Lluis Quintana-Murci et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Serious Infection and Mortality in Patients With Crohn's Disease: More Than 5 Years of Follow-Up in the TREAT™ Registry
Gary R. Lichtenstein et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Abatacept for Crohn's Disease and Ulcerative Colitis
William J. Sandborn et al.
GASTROENTEROLOGY (2012)
Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
Wolfgang Hueber et al.
GUT (2012)
Seven newly identified loci for autoimmune thyroid disease
Jason D. Cooper et al.
HUMAN MOLECULAR GENETICS (2012)
Characterization of TLR4-mediated auto-antibody production in a mouse model of histidyl-tRNA synthetase-induced myositis
Lisa Harlow et al.
INNATE IMMUNITY (2012)
Twin studies in autoimmune disease: Genetics, gender and environment
Dimitrios P. Bogdanos et al.
JOURNAL OF AUTOIMMUNITY (2012)
Rituximab Treatment for Spondyloarthritis. A Nationwide Series: Data from the AIR Registry of the French Society of Rheumatology
Daniel Wendling et al.
JOURNAL OF RHEUMATOLOGY (2012)
TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis
Adam P. Gregory et al.
NATURE (2012)
Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β
Christina E. Zielinski et al.
NATURE (2012)
Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease
Luke Jostins et al.
NATURE (2012)
High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis
Steve Eyre et al.
NATURE GENETICS (2012)
A welcome surprise in psoriasis
James G. Krueger
NATURE MEDICINE (2012)
Effect of a Monoclonal Antibody to PCSK9 on LDL Cholesterol
Evan A. Stein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease
William J. Sandborn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Systematic Review and Meta-Analysis of the Efficacy and Safety of Existing TNF Blocking Agents in Treatment of Rheumatoid Arthritis
Kalle J. Aaltonen et al.
PLOS ONE (2012)
Innate Lymphoid Cells Promote Anatomical Containment of Lymphoid-Resident Commensal Bacteria
Gregory F. Sonnenberg et al.
SCIENCE (2012)
Interactions Between the Microbiota and the Immune System
Lora V. Hooper et al.
SCIENCE (2012)
Integrating Autoimmune Risk Loci with Gene-Expression Data Identifies Specific Pathogenic Immune Cell Subsets
Xinli Hu et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2011)
The value of early intervention in RA-a window of opportunity
Ferdinand Breedveld
CLINICAL RHEUMATOLOGY (2011)
Randomised placebo-controlled trial of rituximab (anti-CD20) in active ulcerative colitis
Keith Leiper et al.
GUT (2011)
Human nutrition, the gut microbiome and the immune system
Andrew L. Kau et al.
NATURE (2011)
The autoimmune disease-associated PTPN22 variant promotes calpain-mediated Lyp/Pep degradation associated with lymphocyte and dendritic cell hyperresponsiveness
Jinyi Zhang et al.
NATURE GENETICS (2011)
Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease
Gosia Trynka et al.
NATURE GENETICS (2011)
Genomics and the Multifactorial Nature of Human Autoimmune Disease
Judy H. Cho et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
The IL23R R381Q Gene Variant Protects against Immune-Mediated Diseases by Impairing IL-23-Induced Th17 Effector Response in Humans
Paola Di Meglio et al.
PLOS ONE (2011)
Functional Studies on the IBD Susceptibility Gene IL23R Implicate Reduced Receptor Function in the Protective Genetic Variant R381Q
Svetlana Pidasheva et al.
PLOS ONE (2011)
Inflammatory disease protective R381Q IL23 receptor polymorphism results in decreased primary CD4+and CD8+human T-cell functional responses
Ritu Sarin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Reengineering Translational Science: The Time Is Right
Francis S. Collins
SCIENCE TRANSLATIONAL MEDICINE (2011)
Different Response to Rituximab in Tumor Necrosis Factor Blocker-Naive Patients With Active Ankylosing Spondylitis and in Patients in Whom Tumor Necrosis Factor Blockers Have Failed A Twenty-Four-Week Clinical Trial
I. -H. Song et al.
ARTHRITIS AND RHEUMATISM (2010)
Th17 and Regulatory T Cells in Mediating and Restraining Inflammation
Dan R. Littman et al.
CELL (2010)
Increased limb involvement in murine collagen-induced arthritis following treatment with anti-interferon-gamma
R. O. WILLIAMS et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Interleukin-23 Drives Intestinal Inflammation through Direct Activity on T Cells
Philip P. Ahern et al.
IMMUNITY (2010)
Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci
John D. Reveille et al.
NATURE GENETICS (2010)
Adaptation - not by sweeps alone
Jonathan K. Pritchard et al.
NATURE REVIEWS GENETICS (2010)
Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis
Christopher E. M. Griffiths et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Trait-Associated SNPs Are More Likely to Be eQTLs: Annotation to Enhance Discovery from GWAS
Dan L. Nicolae et al.
PLOS GENETICS (2010)
Plasticity of CD4+ T Cell Lineage Differentiation
Liang Zhou et al.
IMMUNITY (2009)
PTPN22 Deficiency Cooperates with the CD45 E613R Allele to Break Tolerance on a Non-Autoimmune Background
Julie Zikherman et al.
JOURNAL OF IMMUNOLOGY (2009)
Cutting Edge: The PTPN22 Allelic Variant Associated with Autoimmunity Impairs B Cell Signaling
Adrian F. Arechiga et al.
JOURNAL OF IMMUNOLOGY (2009)
Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathways
Rajan P. Nair et al.
NATURE GENETICS (2009)
A protective function for interleukin 17A in T cell-mediated intestinal inflammation
William O'Connor et al.
NATURE IMMUNOLOGY (2009)
Inflammatory Bowel Disease and Mutations Affecting the Interleukin-10 Receptor
Erik-Oliver Glocker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Mechanisms of Disease: Psoriasis.
Frank O. Nestle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
TGF-β:: A master of all T cell trades
Ming O. Li et al.
CELL (2008)
Innate immunity and intestinal microbiota in the development of Type 1 diabetes
Li Wen et al.
NATURE (2008)
B-cell depletion with Rituximab in relapsing-remitting multiple sclerosis
Stephen L. Hauser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The genetics and immunopathogenesis of inflammatory bowel disease
Judy H. Cho
NATURE REVIEWS IMMUNOLOGY (2008)
T cell-produced transforming growth factor-β1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation
Ming O. Li et al.
IMMUNITY (2007)
A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis
Gerald G. Krueger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Selective costimulation modulation using abatacept in patients with active rheumatoid arthritis while receiving etanercept: a randomised clinical trial
Michael Weinblatt et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes
Michele Cargill et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
A genome-wide association study identifies IL23R as an inflammatory bowel disease gene
Richard H. Duerr et al.
SCIENCE (2006)
Scientific and regulatory considerations on the immunogenicity of biologics
Gopi Shankar et al.
TRENDS IN BIOTECHNOLOGY (2006)
Infliximab for induction and maintenance therapy for ulcerative colitis
P Rutgeerts et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant
T Vang et al.
NATURE GENETICS (2005)
Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study) - A randomized, controlled trial
YPM Goekoop-Ruiterman et al.
ARTHRITIS AND RHEUMATISM (2005)
Abatacept for rheumatoid arthritis refractory to tumor necrosis factor α inhibition
MC Genovese et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
TNF inhibition rapidly down-regulates multiple proinflammatory pathways in psoriasis plaques
AB Gottlieb et al.
JOURNAL OF IMMUNOLOGY (2005)
Epigenetic differences arise during the lifetime of monozygotic twins
MF Fraga et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection:: the PTPN22 620W allele associates with multiple autoimmune phenotypes
LA Criswell et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2005)
Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate
MC Genovese et al.
ARTHRITIS AND RHEUMATISM (2004)
PEST domain-enriched tyrosine phosphatase (PEP) regulation of effector/memory T cells
K Hasegawa et al.
SCIENCE (2004)
Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis
JCW Edwards et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Etanercept as monotherapy in patients with psoriasis
CL Leonardi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease
F Baert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain
DJ Cua et al.
NATURE (2003)
Behcet's disease: a new target for anti-tumour necrosis factor treatment
PP Sfikakis
ANNALS OF THE RHEUMATIC DISEASES (2002)
Mechanisms of disease: The effect of infections on susceptibility to autoimmune and allergic diseases
JF Bach
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor α
JD Gorman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Tumour necrosis factor (TNF) in psoriatic arthritis: pathophysiology and treatment with TNF inhibitors
PJ Mease
ANNALS OF THE RHEUMATIC DISEASES (2002)
Tuberculosis associated with infliximab, a tumor necrosis factor (alpha)-neutralizing agent
J Keane et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
The TSH receptor and its role in thyroid disease
P Kopp
CELLULAR AND MOLECULAR LIFE SCIENCES (2001)
Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial
U Chaudhari et al.
LANCET (2001)
Share Paper
